<?xml version="1.0" ?>
<document id="9bad9c5864165815b35dd2c78cd0ed7b285f0517">
  <chunk id="9bad9c5864165815b35dd2c78cd0ed7b285f0517.c0" text="Receptor Binding Domain Based HIV Vaccines">
    <entity charOffset="9-16" id="9bad9c5864165815b35dd2c78cd0ed7b285f0517.c0.e0" ontology_id="GO_0005488" text="Binding" type="gene_function"/>
  </chunk>
  <chunk id="9bad9c5864165815b35dd2c78cd0ed7b285f0517.c1" text="This paper analyzes the main trend of the development of acquired immunodeficiency syndrome (AIDS) vaccines in recent years. Designing an HIV-1 vaccine that provides robust protection from HIV-1 infection remains a challenge despite many years of effort. Therefore, we describe the receptor binding domain of gp120 as a target for developing AIDS vaccines. And we recommend some measures that could induce efficiently and produce cross-reactive neutralizing antibodies with high binding affinity. Those measures may offer a new way of the research and development of the potent and broad AIDS vaccines.">
    <entity charOffset="66-82" id="9bad9c5864165815b35dd2c78cd0ed7b285f0517.c1.e0" ontology_id="HP_0002721" text="immunodeficiency" type="phenotype"/>
    <entity charOffset="291-298" id="9bad9c5864165815b35dd2c78cd0ed7b285f0517.c1.e1" ontology_id="GO_0005488" text="binding" type="gene_function"/>
    <entity charOffset="479-486" id="9bad9c5864165815b35dd2c78cd0ed7b285f0517.c1.e2" ontology_id="GO_0005488" text="binding" type="gene_function"/>
    <pair e1="9bad9c5864165815b35dd2c78cd0ed7b285f0517.c1.e0" e2="9bad9c5864165815b35dd2c78cd0ed7b285f0517.c1.e1" id="9bad9c5864165815b35dd2c78cd0ed7b285f0517.c1.p0" relation="true"/>
    <pair e1="9bad9c5864165815b35dd2c78cd0ed7b285f0517.c1.e0" e2="9bad9c5864165815b35dd2c78cd0ed7b285f0517.c1.e2" id="9bad9c5864165815b35dd2c78cd0ed7b285f0517.c1.p1" relation="true"/>
  </chunk>
</document>
